DailyFinance GLUMETZA (metformin hydrochloride extended release tablets) and CYCLOSET (bromocriptine mesylate) tablets, which are indicated as adjuncts to diet and exercise to improve glycemic control in adults with type 2 diabetes, and FENOGLIDE ( fenofibrate ) ...
Daily News & Analysis The Barclays analysts noted that Lupin continues to perform with a 59% year on year growth in April on the back of market share gains across key products like Cefdinir and Lamivud, in addition to sustained share in key products like Fenofibrate and ...
pharmabiz.com Fenofibrate tablets are indicated as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), Triglycerides and apolipoprotein B (Apo B), and to increase high-density lipoprotein ... and more »
Irish Medical Times Losartan may be used in the hypertensive patient with hyperuricaemia and fenofibrate for the treatment of hyperlipidaemia to bring about further reductions in serum urate. In appropriately-selected severe cases, combination therapy of a xanthine ... and more »
7thSpace Interactive (press release) Although both compounds are more potent PPARalpha-activators than fenofibrate in vitro, only aleglitezar is more effective in lowering triglycerides and raising high-density lipoprotein-cholesterol (HDL-C) in humans. However, it is also associated with ...
7thSpace Interactive (press release) Although both compounds are more potent PPARalpha-activators than fenofibrate in vitro, only aleglitezar is more effective in lowering triglycerides and raising high-density lipoprotein-cholesterol (HDL-C) in humans. However, it is also associated with ...
Seeking Alpha The company's current commercial efforts are focused on five products: UCERIS™ (budesonide) extended release tablets for the induction of remission in patients with active, mild to moderate ulcerative colitis and ZEGERID® ( omeprazole /sodium ...
7thSpace Interactive (press release) Although both compounds are more potent PPARalpha-activators than fenofibrate in vitro, only aleglitezar is more effective in lowering triglycerides and raising high-density lipoprotein-cholesterol (HDL-C) in humans. However, it is also associated with ...
